Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its structural configuration supports high enantioselectivity, making it valuable in asymmetric synthesis for active pharmaceutical ingredients (APIs). Also employed in the preparation of pyrrolidine-based catalysts and ligands for organic transformations.